País: Suiza
Idioma: italiano
Fuente: Swissmedic (Swiss Agency for Therapeutic Products)
neostigmini metilsulfas
MEDA Pharmaceuticals Switzerland GmbH
N07AA01
neostigmini metilsulfas
Soluzione iniettabile
neostigmini metilsulfas 12.5 mg, natrii chloridum, conserv.: phenolum 20 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
B
Synthetika
Cholinergicum, Antimyasthenicum
zugelassen
1952-04-25